Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF 7 breast cancer cells

Biochem Biophys Res Commun. 1989 Jul 14;162(1):415-21. doi: 10.1016/0006-291x(89)92013-5.

Abstract

Previous studies have demonstrated an inverse relationship between estrogen receptor (ER) and epidermal growth factor receptor (EGF-R) gene expression in human breast cancer cells. This relationship was further investigated in MCF 7 cells treated with 12-O-tetradecanoylphorbol-13-acetate (TPA). Exposure to 10 nM TPA resulted in a time-dependent increase in EGF-R mRNA, first apparent at 3 h and maximal between 9 and 24 h. There was a concomitant fall in ER mRNA with a maximum decline to 15-20% of control between 12 and 24 h. Although EGF-R mRNA levels declined between 24 and 72 h, both EGF-R mRNA and EGF-R binding remained above control levels and this was accompanied by a sustained depression of ER mRNA. These data support the view that ER and EGR-R gene expression is inversely regulated in human breast cancer and describe for the first time an inhibitory effect of a phorbol ester on steroid hormone receptor gene expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Cell Division / drug effects
  • Cell Line
  • ErbB Receptors / drug effects*
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism
  • Gene Expression Regulation / drug effects
  • Humans
  • Neoplasm Proteins / biosynthesis
  • RNA, Messenger / metabolism*
  • Receptors, Estrogen / drug effects*
  • Receptors, Estrogen / genetics
  • Receptors, Estrogen / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism
  • Tumor Cells, Cultured / pathology

Substances

  • Neoplasm Proteins
  • RNA, Messenger
  • Receptors, Estrogen
  • ErbB Receptors
  • Tetradecanoylphorbol Acetate